- 1.Camouflaged Nanozyme with Oxidation-Promoting Activities Triggering Ferroptosis for Radioimmunotherapy
- 2.Biomimetic nano-chelate diethyldithiocarbamate Cu/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy
- 3.Inflammatory Fibroblast‐Like Synoviocyte‐Derived Exosomes Aggravate Osteoarthritis via Enhancing Macrophage Glycolysis
“和元李记”由和元生物 (股票代码:688238) 和李记生物合资成立的,主营“李记生物”“Life-ilab”试剂品牌
返回






